Lin CA, Chica-Parrado MR, Unni N, Jaeger E, et al. ESR1 Y537S and D538G mutations drive resistance to CDK4/6 inhibitors in estrogen receptor-positive breast cancer. Clin Cancer Res 2025 Feb 25. doi: 10.1158/1078-0432.CCR-24-2307.
PMID: 39992682